CC
AMLX icon

Cipher Capital’s Amylyx Pharmaceuticals AMLX Stock Holding History

Cipher Capital’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$30.4K Buy
+10,717
New +$140K 0.01% 411

Other funds holding AMLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cipher Capital's AMLX Position: Q1 2024 in Review

Cipher Capital opened a new position in Amylyx Pharmaceuticals (AMLX) in Q1 2024: 10,717 shares worth $30.4K. The stake represents 0.01% of the portfolio and ranks #411 among its holdings.

143 funds tracked by Wall St. Rank hold AMLX as of Q1 2024.

  • Cipher Capital held 10,717 shares of Amylyx Pharmaceuticals worth $30.4K as of Q1 2024.
  • Amylyx Pharmaceuticals was a new Cipher Capital position in Q1 2024.
  • Amylyx Pharmaceuticals made up 0.01% of Cipher Capital's portfolio in Q1 2024, its #411 holding.
  • 143 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q1 2024.

Based on Cipher Capital's 13F filing for Q1 2024, filed 15 May 2024.